chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a licensed practical nurse refers to unspecified patients of unknown age (gender unspecified). On an unknown date, the patients were vaccinated with VAQTA (lot number, expiration and route not reported). No concomitant medications were reported. The nurse stated that her office had improperly stored VAQTA. The reporter stated it was possible that an unspecified number of patients might have been administered with the improperly stored vaccine. No symptoms were reported. This is one of the several report received from the same reporter. Additional information has been requested.
confusion; fever of 104; injection site still sore; headache; body aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CONFUSIONAL STATE (confusion), VACCINATION SITE PAIN (injection site still sore), HEADACHE (headache) and MYALGIA (body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: BACTRIM (He was on Bactrim prior to the vaccine.He has been on Bactrim for two and a half days.). Concurrent medical conditions included Allergy (Allergic to Bactrim medication.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced CONFUSIONAL STATE (confusion), VACCINATION SITE PAIN (injection site still sore), HEADACHE (headache) and MYALGIA (body aches). On 22-Jan-2021, CONFUSIONAL STATE (confusion), VACCINATION SITE PAIN (injection site still sore), HEADACHE (headache) and MYALGIA (body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included discontinuing Bactrim.  No concomitant medication was provided.
Responded to alarm for bradycardia/desaturation. Infant noted to have central cyanosis, HR in 70's initially and O2 sats in 30's, with no improvement with stimulation. Infant noted to be apneic and HR/O2 sats falling. Began PPV 20/5 at 30% FiO2 and called for RN to bedside, who notified NNP to come to bedside for apneic infant who was not responsive to stimulation and sats not improving despite PPV. FiO2 increased gradually to a max of 60% and infant suctioned with neosucker once NNP x2 arrived at bedside. Continue PPV x 3 minutes. Infant began spontaneously breathing, and PPV discontinued. CPAP of 5 given briefly, then discontinued and infant placed back on HFNC of 2L and FiO2 weaned as tolerated.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided. Expired vaccines were administered between 20-Oct-2021 to 29-Nov-2021 Patient didn't take treatment
29 weeks pregnant with normal pregnancy. Pfizer-BioNTechb COVID-19 VACCINE EUA  Sore armv within 24 hours. Needed heat bad. About 20 hours after injection extremely tired and couldn't start awake. Chills and hotsweats that night.  Side effects gone within 36 hours.
Felt hot; Knees aching; Fever; Sore arm/arm pain; Could not move her arm; whole arm went numb; Arm felt weird and painful; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (whole arm went numb), LIMB DISCOMFORT (Arm felt weird and painful), FEELING HOT (Felt hot), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not move her arm) and ARTHRALGIA (Knees aching) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lupus erythematosus systemic. Concomitant products included HYDROXYCHLOROQUINE for Lupus syndrome.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced HYPOAESTHESIA (whole arm went numb), LIMB DISCOMFORT (Arm felt weird and painful), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not move her arm) and VACCINATION SITE PAIN (Sore arm/arm pain). On 17-Apr-2021, the patient experienced FEELING HOT (Felt hot), ARTHRALGIA (Knees aching) and PYREXIA (Fever). The patient was treated with IBUPROFEN on 17-Apr-2021 at a dose of 200 mg three times a day. On 18-Apr-2021, FEELING HOT (Felt hot), ARTHRALGIA (Knees aching) and PYREXIA (Fever) had resolved. On 19-Apr-2021, HYPOAESTHESIA (whole arm went numb), LIMB DISCOMFORT (Arm felt weird and painful), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not move her arm) and VACCINATION SITE PAIN (Sore arm/arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021. TCR received: updated events.
Muscle soreness, chills, fever, stiffness,  insomnia. Took Tylenol. Symptoms abated after 24 hours.
presented to ED 3 days post injection with c/o palpatations and some SOB,. Patient was found to be in AFib with RVR.  Labs showed severe hypokalemia.  Three doses of potassium chloride were administered with improvement of potassium.  Patient underwent a DC cardioversion   Patient also reported positive COVID 19 test on 1/15/2021
patient w/ history of laryngeal cancer; has a total laryngectomy with reconstructive surgery in April 2021; recovered; took the vaccine in june/July. in August 2021, presented with ear pain again, like when first diagnosed; CT revealed recurrence; pt then had a bleed and possible carotid blow out; presented to hospital for embolization; pt coded and died a few days later
Pt experienced vasovagal syncope within 15 minutes of vaccination. Supportive care provided and pt recovered without incidence.
head congestion, sinus pain, green mucus, no fever; pt says dx was sinusitis; ATB given x 2; pt & MD do not feel this is any connection to flu vax;
Patient called me on 12/09 and she said after receiving her vaccine on 12/6 she started experiencing redness and hot in the arm ( the same night) she used cold compresses but didn't help, I advised her to take Benadryl 75 mg every 8 hours , she just took it once and she stopped , few hours after the first dose of Benadryl, she started having the same problem, today (12/9) she said the front of her arm started getting red, I asked her to come to pharmacy, I looked at it , the lower part of arm was completely red and painful to touch, the upper part of arm started getting red as well, she mentioned the first day she had fever as well, I asked her to continue taking benadryl and she can take advil and I asked her if it did not get better or got worst, she has to call her doctor office and pharmacy.
Large inflamed  red welts   that that begin with extremely bad itching all over body.... At first it was just on my torso, but now it  has spread to my legs and face. I am treating it with increased dosages of antihistamines , hydrocortisone cream, and  oatmeal lotion.  It flares up randomly.
pain around her neck; This is a spontaneous report from a contactable physician. A female patient of a age 34, unit was unknown received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no. was not reported), dose 1st subcutaneous on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient experienced a lot of pain around her neck. Reporter would like to verify if there's a concern getting the second dose of the vaccine. Reporter like to know if there's updated information on the duration of protection after receiving the Pfizer-BioNtech Covid-19 vaccine, if there's information on the other data on transmissibility of the virus in people who has been vaccinated. Also, if there's any updated information from the Phase 3 trials population who tested positive for Covid-19. The number of individuals who have tested positive since the vaccine and the quantity of virus detected, and also if if there's updated information on the transmissibility of the virus in people who has been vaccinated with the Pfizer-BioNtech Covid-19 vaccine. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Information has been received from a pharmacist referring to a patient of unknown age and gender. No current condition and medical history was reported. On 13-APR-2015, the patient was not vaccinated with full dose of ZOSTAVAX (lot # K020187, Exp. 27-JAN-2016, dose and route not reported) which was draw up into a plastic syringe and the needle leaked. No adverse effects reported. Additional information has been requested.
Pt received Moderna 1st dose at 12:11.  12:20 Felt Flush.  12:28 felt tingling all over body, diaphoretic.  12:30 BP - 60/35, HR 80 100% RA. Physician notified.  Physician  arrived and evaluated pt.  Pt placed on a gurney trendeleberg.  12:40 BP - 137/35, 88, 110% RA. Complained of nausea.12:45 113/64 73, 100% RA.  Patient remain in the clinic for observation.  Husband picked up patient.
Red dots in back of throat; slightly swollen tongue and uvula; slightly swollen tongue and uvula; This is a spontaneous report from a contactable other HCP (patient).   A 19-year-old non pregnant female patient received bnt162b2 (Pfizer BioN Tech Covid-19 MRNA vaccine, Formulation: Solution for injection, Batch/Lot number: Unknown) via unspecified route of administration administered in Right arm as Dose 1, Single on 10Feb2021 (age at the time of vaccination was 19-year-old), (at 11:00) for Covid-19 immunisation. The patient medical history included asthma. Concomitant medication included Prozac and Ibuprofen in two weeks. The patient did not receive other vaccine in 4 weeks. The patient did not receive covid vaccination priorly and not tested for covid post vaccination. The patient experienced Red dots in back of throat, not painful, slightly swollen tongue and uvula on 10Feb2021 (at 14:30). The patient received Benadryl as a treatment. Outcome of all the events was not recovered.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Within 2 days of getting the vaccine, I had a rash appear on my hip. It was an Erythema annulare centrifugum (EAC) rash. The dermatologist I saw said to let it be and it should resolve on its own. He said it could very well have been related to the vaccine, but he couldn't say for certain.
No other adverse effects; 73 year old patient received a dose of VAQTA in 2018, and received a pediatric dose yesterday; 73 year old patient received a dose of VAQTA in 2018, and received a pediatric dose yesterday; This spontaneous report as received from a nurse refers to a 73-year-old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date in 2018l, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On 10-JUN-2020 (reported as yesterday), the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) strength reported as 25/0.5, 0.5 ml (route of administration, lot # and expiration date were not reported) for prophylaxis. There was no adverse event reported.
Clusters of nontender, slightly pruritic small reddish-purple papular rash bilateral dorsal hands, bridge of nose and cheeks, expanding. Initial left upper arm soreness at injection site which has since resolved.
Dizziness; Swelling at injection site; Pain at injection site; Tired/fatigue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. The patient had received other medication within two weeks of vaccination. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 15:00, the patient experienced swelling at the injection site, pain at the injection site that worsened into the night, dizziness and tired/fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events swelling at the injection site, pain at the injection site, dizziness and tired/fatigue was recovering at the time of the report.  No follow-up attempts are needed; information about the lot number cannot be obtained.
"after 15mins start having headachex2 days, next day nauseous, bone pain, palpitations, fever 103.9 BP 195/98 pulse 154 , O2 sat 94% on RA ,  and  body aches pain#6, chills, shaking, rash on my legs and itching next 2 days, and then I got left axillary lump  so painful #9 for 2 weeks and vaccine  area was red,  inflamed ,itchy for 3 weeks
Caller is a nurse calling to report a temperature excursion involving PROQUAD and VARlCELLA.; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not reported.  On 09-DEC-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), at a dose of 0.5 milliliter, as prophylaxis (formulation, strength, vaccination scheme, route of administration and anatomical site of vaccination were not provided, lot number T021302 which has been verified to be valid, expiration date reported as 29-DEC-2021, but upon internal review it was established as 19-DEC-2021), on an unknown date, the patient received varicella virus vaccine live (oka/merck) (VARIVAX), as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not reported). Both vaccines experienced a temperature excursion on 2 separate dates of -5 degrees Celsius (C) for 20 hours, by a time frame of 20 hours, as recorded by a data logger. There was no previous temperature excursion reported.
My son had the DTaP vaccine the beginning of August and by mid to late August developed a rash similar to eczema or dermatitis on his ankle then his legs. We have been to the doctors several times for this rash. No one can tell us exactly what is causing it. Steroid cream and antihistamine are not helping much. It's now October and it's still all over both of his legs and a little on his arms. It is somewhat itchy but nothing too bad. It doesn't appear to be eczema to me personally. It's just little red raised bumps all over his legs. Nothing is helping it clear up and it's getting worse.
Erythematous macularpapular rash on right thigh/hip posterior to site of injection.
Later same evening, fever and extremely irritable. Began with nasal congestion and cough. Persisting with poor nursing and poor formula intake.
Flu and DTaP both given. Muscle pain in left arm that never went away. Some tingling starting to happen now (10/17).
Patient stated they felt dizzy, had tunnel vision and was drenched in sweat. He then fell and hit head. Patient was given an ice pack for head and was given an ice pop to chew. He was watched for approx. 15-20 minutes and walked out without assistance.
pt recv vax 24AUG95 & devel chickenpox 5APR97;therapeutic failure;
brief = myopericarditis  detailed = 13 y.o. male with no significant past medical history who presents following 2 days of sternal chest pain and shortness of breath following exercise. Of note, he just received the Covid-19 vaccine booster (3rd dose, Pfizer) four days ago, Friday 1/14/22.  He had no specific reaction following the first two doses of the Covid vaccine, however following third booster dose began to have new onset symptoms. On post-vaccine day 1 (1/15/22) he had vague symptoms of fatigue / tiredness, but otherwise able to continue all usual activities. On Sunday 1/16/22, he began to have feelings of L upper sternal chest pain and shortness of breath with exercise (was skiing with family) and when going up stairs. This continued on 1/17/22 prompting them to go to their PCP. Based on this history of chest pain, an EKG was performed which was interpreted as possible ST segment changes consistent with pericarditis vs. early repolarization. We were contacted and, given the history and ECG findings concerning for Covid-19 mRNA vaccine associated myo/pericarditis, we recommended evaluation in clinic today. Also recommended starting scheduled ibuprofen q 8hrs, which they took last night and this morning.    One further questioning, he continues to have the chest pain. Has been fairly constant, feels like squeezing quality pain at top of sternum. No changes with breathing or when pushing on chest. Broadly, was a full-term infant with no significant problems during pregnancy, delivery, or in the immediate newborn period. No prior cardiac concerns. He is now a fairly active child and participates in multiple activities with his friends and family. He is generally able to keep pace with his friends during activity. A complete ROS is below, but they deny any episodes of cyanosis, syncope, color change, or other concerning signs/symptoms associated with current pain.  EKG that day showed new T-wave inversion in right precordial leads (see below)
Information has been received from a medical assistant to multiple, unspecified patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with doses of improperly PEDVAXHIB (strength, frequency and route not reported, lot # L038501 and Expiration date 16-AUG-2018). The vaccines were exposed to 11.7 degree Celsius for 84 minutes. There was no previous temperature excursion. The temperature was back in range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
After injection of Varivax #2 in R arm and HPV #1 in L arm she fainted.
pt recv vax & devel massive swelling @ the site of inj which lasted 3wk;pt has a hx of hives from eggs;pt has recovered;
Within 1 week had breathing trouble and fatigue. Following months experiencing hair loss, fatigue, stomach problems, brain fog.
Pain and some swelling in lmpyhnodes; Pain and some swelling in lmpyhnodes; Also developed lactose intolerance or ibs after injections; Also developed lactose intolerance or ibs after injections; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 30Mar2021 at 13:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date taken within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021 the patient experienced continued pain and some swelling in lmpyhnodes even after four months later. The patient had also developed lactose intolerance or ibs after injections. The patient never had tummy issues with eating certain foods until the shot. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. O The clinical outcome of the events continued pain and some swelling in lmpyhnodes, and lactose intolerance or ibs were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Information has been received from a healthcare professional referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored oral, ROTATEQ (lot # L008034 with expiration date of 05-AUG-2016; lot# L022447 with expiration date of 26-FEB-2017; strength, dosage, frequency and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 82-year-old male patient received BNT162b2 (BNT162B2), on 18Feb2021 as dose number unknown, single (Lot number: el9267), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The patient did not receive any other medications within 2 weeks of vaccination. It was reported that the patient did not have known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of covid-19. Follow-up attempts are completed. No further information is expected.
Patient experienced hair loss starting around 2/6 - 2/12. He reports hair coming out with just running his hand through his hair. Does not report trying any agents to improve problem.
pt recvd vax 12JUL93 called clinic 15JUL93; c/o raw feeling throat, muscle aches, no energy; pt on steroids did not diclose @ time of vax; low grade fever;
Case completed covid vaccine series in March 2021 then was hospitalized for Covid in October 221.  * Acute hypoxemic respiratory failure due to COVID-19 (HCC) Assessment & Plan Fully vaccinated, tested positive for SARS-CoV-2 October 18. Had N/V/D which have improved.  Symptom onset about October 16, fevers chills cough nausea diarrhea myalgias  -Hypoxia at home to mid 80s.   -On arrival systemic inflammatory syndrome, sepsis secondary to viral pneumonia.  CRP up at 24.7 but down to 4.7 on the day of d/c.  -Dexamethasone 6 mg and remdesivir started October 24, will continue cecadron for 6 more days.  - Continue to wean supplemental oxygen as able. Improved symptoms and o2 supplement down to 1L/min, doing ADLs with mild symptoms.   - Encourage self proning as able, IS and ambulation.  - Note that is DNR/DNI but is agreeable to HFNC, NIPPV, and ICU transfer if needed